Vimarsana
Biggest News Aggregation in the World

Page 4 - Compass Pathways News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Compass Pathways. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Compass Pathways Today - Breaking & Trending Today

Insider Selling: COMPASS Pathways plc (NASDAQ:CMPS) Major Shareholder Sells $203,704.93 in Stock - Vimarsana News

Insider Selling: COMPASS Pathways plc (NASDAQ:CMPS) Major Shareholder Sells $203,704.93 in Stock

COMPASS Pathways plc (NASDAQ:CMPS – Get Free Report) major shareholder George Jay Goldsmith sold 23,881 shares of the stock in a transaction dated Tuesday, April 16th. The shares were sold at an average price of $8.53, for a total value of $203,704.93. Following the completion of the transaction, the insider now directly owns 3,986,523 shares […]

Jim Cramer Slams Political Blocking Of 'LSD-Derived Antidepressants,' Citing Strong Test Data 'Showing They Worked' - Vimarsana News

Jim Cramer Slams Political Blocking Of 'LSD-Derived Antidepressants,' Citing Strong Test Data 'Showing They Worked'

Jim Cramer recently hyped up one of his guests in advance of his CNBC show "Mad Money," posting on X that people "will be very interested in MindMed for certain ... LSD," and he made sure his interview did not disappoint. Mind Medicine Inc. (NASDAQ:MNMD) sees a massive market opportunity ahead, citing 21% of U.S. adults with an anxiety disorder, an estimated 4.4% of U.S. adults with attention-deficit/hyperactivity disorder (ADHD) and a $461 billion economic cost from autism spectrum disorder by

Source: yahoo.com
COMPASS Pathways plc (NASDAQ:CMPS) Given Average Rating of "Buy" by Brokerages - Vimarsana News

COMPASS Pathways plc (NASDAQ:CMPS) Given Average Rating of "Buy" by Brokerages

Shares of COMPASS Pathways plc (NASDAQ:CMPS – Get Free Report) have been given an average rating of “Buy” by the six research firms that are currently covering the company, MarketBeat.com reports. Six investment analysts have rated the stock with a buy rating. The average 1 year target price among analysts that have updated their coverage […]

Analysts Set COMPASS Pathways plc (NASDAQ:CMPS) Target Price at $49.00 - Vimarsana News

Analysts Set COMPASS Pathways plc (NASDAQ:CMPS) Target Price at $49.00

COMPASS Pathways plc (NASDAQ:CMPS – Get Free Report) has been given a consensus rating of “Buy” by the six analysts that are covering the company, MarketBeat Ratings reports. Six research analysts have rated the stock with a buy recommendation. The average 12 month price objective among brokers that have issued ratings on the stock in […]

Insider Selling: COMPASS Pathways plc (NASDAQ:CMPS) Major Shareholder Sells $222,737.50 in Stock - Vimarsana News

Insider Selling: COMPASS Pathways plc (NASDAQ:CMPS) Major Shareholder Sells $222,737.50 in Stock

COMPASS Pathways plc (NASDAQ:CMPS – Get Free Report) major shareholder Ekaterina Malievskaia sold 25,750 shares of the business’s stock in a transaction on Thursday, March 28th. The shares were sold at an average price of $8.65, for a total transaction of $222,737.50. Following the completion of the sale, the insider now directly owns 4,036,154 shares […]

Source: wkrb13.com